Exact Sciences (EXAS) Other financing activities (2017 - 2025)
Exact Sciences has reported Other financing activities over the past 9 years, most recently at -$1.7 million for Q4 2025.
- Quarterly Other financing activities rose 21.76% to -$1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.9 million through Dec 2025, up 33.05% year-over-year, with the annual reading at -$11.9 million for FY2025, 33.05% up from the prior year.
- Other financing activities was -$1.7 million for Q4 2025 at Exact Sciences, up from -$1.7 million in the prior quarter.
- Over five years, Other financing activities peaked at -$417000.0 in Q4 2022 and troughed at -$11.6 million in Q2 2024.
- The 5-year median for Other financing activities is -$1.7 million (2021), against an average of -$2.5 million.
- Year-over-year, Other financing activities plummeted 903.64% in 2024 and then skyrocketed 84.13% in 2025.
- A 5-year view of Other financing activities shows it stood at -$544000.0 in 2021, then rose by 23.35% to -$417000.0 in 2022, then crashed by 443.65% to -$2.3 million in 2023, then rose by 2.51% to -$2.2 million in 2024, then grew by 21.76% to -$1.7 million in 2025.
- Per Business Quant, the three most recent readings for EXAS's Other financing activities are -$1.7 million (Q4 2025), -$1.7 million (Q3 2025), and -$1.8 million (Q2 2025).